Top compounds associated with response to UBD


Feature Type Standardized
Nominal ANOVA
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA CIL55A CTRPv2 pan-cancer AAC -0.042 0.4
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.026 0.4
mRNA etoposide CTRPv2 pan-cancer AAC 0.023 0.4
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA alvocidib CTRPv2 pan-cancer AAC -0.036 0.5
mRNA BRD1835 CTRPv2 pan-cancer AAC -0.029 0.5
mRNA ML239 CTRPv2 pan-cancer AAC -0.027 0.5
mRNA MK-0752 CTRPv2 pan-cancer AAC -0.029 0.5
Download CSV